Valerie Baker, M.D.

Obstetrician/Gynecologist, Fertility specialist

Associate Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at the Stanford University Medical Center

Fertility and Reproductive Medicine Center

  • 900 Welch Road
  • Palo Alto, CA 94304
  • Phone: 650-498-7911
Learn More About the Clinic Getting Here Make An Appointment

International Azoospermia Center

  • 1000 Welch Road
  • Palo Alto, CA 94304
  • Phone: 650-723-3391
Learn More About the Clinic Getting Here Make An Appointment

Gynecology Clinic

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-725-6079
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: UCSF Medical Center (6/30/1995) CA

Residency: UCSF - Department of OB/GYN and REI (6/30/1992) CA

Medical Education: Harvard Medical School (6/9/1988) MA

Board Certification: Reprod. Endocrinology and Infertility, American Board of Obstetrics and Gynecology (1998)

Board Certification: Obstetrics and Gynecology, American Board of Obstetrics and Gynecology (1996)

MD, Harvard Medical School, Medicine (1988)

Master's, Harvard (Kennedy School of Government), Health Policy (1988)

Honors & Awards

Selected for the Stanford Advanced Leadership Program, Stanford University (2012-2013)

Selected for the 2012 School of Medicine Faculty Fellows Program, Office of Diversity and Leadership Stanford University (2012)

American Society for Reproductive Medicine Star Award, American Society for Reproductive Medicine (2011)

American Society for Reproductive Medicine Service Award, American Society for Reproductive Medicine (2010)

National Register's Who's Who, National Register's Who's Who (2004)

Best Doctors in America, Best Doctors in America (2004-2011)

Clinical Research/Reproductive Endocrinology Scientist Scholar, National Institute of Health (2005-2006)

American College of Obstetricians and Gynecologists/Ortho Fellowship, American College of Obstetricians and Gynecologists (1994-1995)

American College of Obstetricians and Gynecologists/Mead Johnson Fellowship, American College of Obstetricians and Gynecologists (1993-1994)

Administrative Appointments

Division Chief, Div. Reproductive Endocrinology and Infertility, Dept. Obstetrics and Gynecology Stanford University (2012 - Present)

Acting Division Chief, Div. Reproductive Endocrinology and Infertility, Dept. Obstetrics and Gynecology Stanford University (2008 - 2012)

Membership Services Committee Co-Chair, Society for Reproductive Endocrinology and Infertility (2011 - Present)

Members Practice Retreat Co-Chair, Society for Reproductive Endocrinology and Infertility (2011 - Present)

Research Committee Chair, Society for Assisted Reproductive Technologies (2010 - Present)

Executive Council, Society for Assisted Reproductive Technologies (2009 - Present)

Vice President/ Board of Directors, Rachel's Well (2009 - Present)

Medical Director, Stanford Fertility and Reproductive Medicine Center (2007 - Present)

Director, Primary Ovarian Insufficiency Program, Stanford Fertility and Reproductive Medicine Center (2009 - Present)

Board of Directors, Society for Reproductive Endocrinology and Infertility (2006 - Present)

Board of Directors, Pacific Coast Reproductive Society (2006 - 2009)

Practice Committee, Society for Reproductive Endocrinology and Infertility (2008 - 2011)

Postgraduate Program Chair, American Society for Reproductive Medicine (2007 - 2008)

Postgraduate Program Co-Chair, American Society for Reproductive Medicine (2006 - 2007)

Postgraduate Program Coordinating Chair, American Society for Reproductive Medicine (2005 - 2006)

Stem Cell Research Oversight Committee, Stanford University (2007 - 2009)

Medical Director, Fertility Physicians of Northern California (2004 - 2007)

Medical Director, University of Washington Assisted Reproductive Technology Program (1999 - 2000)

Patient Education Committee, American Society for Reproductive Medicine (1999 - 2005)

President, American Medical Women's Association of the South Bay (2004 - 2005)

Treasurer, American Medical Women's Association of the South Bay (2003 - 2004)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Maximizing the clinical utility of antimüllerian hormone testing in women's health.
Leader, B., & Baker, V. L. (2014). Maximizing the clinical utility of antimüllerian hormone testing in women's health. Current opinion in obstetrics & gynecology, 26(4), 226-236.

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., & Zhang, H. (2014). Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. NEW ENGLAND JOURNAL OF MEDICINE, 371(2), 119-129.

Conjugated bisphenol A in maternal serum in relation to miscarriage risk.
Lathi, R. B., Liebert, C. A., Brookfield, K. F., Taylor, J. A., vom Saal, F. S., & Baker, V. L. (2014). Conjugated bisphenol A in maternal serum in relation to miscarriage risk. Fertility and sterility, 102(1), 123-128.

Preimplantation Diagnosis for Single Gene Disorders
Berger, V. K., & Baker, V. L. (2014). Preimplantation Diagnosis for Single Gene Disorders. SEMINARS IN REPRODUCTIVE MEDICINE, 32(2), 107-113.

The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., & Zhang, H. (2014). The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial. FERTILITY AND STERILITY, 101(1), 258-?.

Second try: who returns for additional assisted reproductive technology treatment and the effect of a prior assisted reproductive technology birth
Luke, B., Brown, M. B., Wantman, E., Baker, V. L., Grow, D. R., & Stern, J. E. (2013). Second try: who returns for additional assisted reproductive technology treatment and the effect of a prior assisted reproductive technology birth. FERTILITY AND STERILITY, 100(6), 1580-1584.

Primary ovarian insufficiency in the adolescent
Baker, V. L. (2013). Primary ovarian insufficiency in the adolescent. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 25(5), 375-381.

Frequency of the Male Infertility Evaluation: Data from the National Survey of Family Growth
Eisenberg, M. L., Lathi, R. B., Baker, V. L., Westphal, L. M., Milki, A. A., & Nangia, A. K. (2013). Frequency of the Male Infertility Evaluation: Data from the National Survey of Family Growth. JOURNAL OF UROLOGY, 189(3), 1030-1034.

Mild ovarian stimulation for in vitro fertilization: one perspective from the USA
Baker, V. L. (2013). Mild ovarian stimulation for in vitro fertilization: one perspective from the USA. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 30(2), 197-202.

Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies\
Conrad, K. P., & Baker, V. L. (2013). Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies\. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 304(2), R69-R72.

Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series
Lathi, R. B., Massie, J. Am., Gilani, M., Milki, A. A., Westphal, L. M., & Behr, B. (2012). Outcomes of trophectoderm biopsy on cryopreserved blastocysts: a case series. REPRODUCTIVE BIOMEDICINE ONLINE, 25(5), 504-507.

Elevated Prevalence of 35-44 FMR1 Trinucleotide Repeats in Women With Diminished Ovarian Reserve
Pastore, L. M., Young, S. L., Baker, V. L., Karns, L. B., Williams, C. D., & Silverman, L. M. (2012). Elevated Prevalence of 35-44 FMR1 Trinucleotide Repeats in Women With Diminished Ovarian Reserve. REPRODUCTIVE SCIENCES, 19(11), 1226-1231.

High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers
Leader, B., Hegde, A., Baca, Q., Stone, K., Lannon, B., & Baker, V. L. (2012). High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers. FERTILITY AND STERILITY, 98(4), 1037-1042.

Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes
Wellons, M. F., Fujimoto, V. Y., Baker, V. L., Barrington, D. S., Broomfield, D., & Armstrong, A. Y. (2012). Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. FERTILITY AND STERILITY, 98(2), 406-409.

Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging. FERTILITY AND STERILITY, 97(4), 843-851.

Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 19(4), 387-395.

Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging. CLIMACTERIC, 15(2), 105-114.

Executive Summary of the Stages of Reproductive Aging Workshop+10: Addressing the Unfinished Agenda of Staging Reproductive Aging
Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., & de Villiers, T. J. (2012). Executive Summary of the Stages of Reproductive Aging Workshop+10: Addressing the Unfinished Agenda of Staging Reproductive Aging. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97(4), 1159-1168.

Early pregnancy testosterone after ovarian stimulation and pregnancy outcome
Gustin, S. Lf., Mukherjee, G., Baker, V. L., Westphal, L. M., Milki, A. A., & Lathi, R. B. (2012). Early pregnancy testosterone after ovarian stimulation and pregnancy outcome. FERTILITY AND STERILITY, 97(1), 23-U48.

An assessment of female university students' attitudes toward screening technologies for ovarian reserve
Bavan, B., Porzig, E., & Baker, V. L. (2011). An assessment of female university students' attitudes toward screening technologies for ovarian reserve. FERTILITY AND STERILITY, 96(5), 1195-1199.

Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper
Ginsburg, E. S., Baker, V. L., Racowsky, C., Wantman, E., Goldfarb, J., & Stern, J. E. (2011). Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper. FERTILITY AND STERILITY, 96(4), 865-868.

Life Plans and Family-Building Options for Women with Primary Ovarian Insufficiency
Baker, V. (2011). Life Plans and Family-Building Options for Women with Primary Ovarian Insufficiency. SEMINARS IN REPRODUCTIVE MEDICINE, 29(4), 362-372.

The time is now for a new approach to primary ovarian insufficiency
Cooper, A. R., Baker, V. L., Sterling, E. W., Ryan, M. E., Woodruff, T. K., & Nelson, L. M. (2011). The time is now for a new approach to primary ovarian insufficiency. FERTILITY AND STERILITY, 95(6), 1890-1897.

Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States
Seifer, D. B., Baker, V. L., & Leader, B. (2011). Age-specific serum anti-Mullerian hormone values for 17,120 women presenting to fertility centers within the United States. FERTILITY AND STERILITY, 95(2), 747-750.

Day 2 versus day 3 embryo transfer in poor responders: a prospective randomized trial
Shahine, L. K., Milki, A. A., Westphal, L. M., Baker, V. L., Behr, B., & Lathi, R. B. (2011). Day 2 versus day 3 embryo transfer in poor responders: a prospective randomized trial. FERTILITY AND STERILITY, 95(1), 330-332.

Age-Related Success with Elective Single versus Double Blastocyst Transfer.
Friedman, B. E., Davis, L. B., Lathi, R. B., Westphal, L. M., Baker, V. L., & Milki, A. A. (2011). Age-Related Success with Elective Single versus Double Blastocyst Transfer. ISRN obstetrics and gynecology, 2011, 656204-?.

Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage
Scriver, J., Baker, V. L., Young, S. L., Behr, B., & Pastore, L. M. (2010). Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 8.

The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study
Lewis, M., Baker, V., & Nezhat, C. (2010). The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. FERTILITY AND STERILITY, 94(6), E81-E82.

Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System
Baker, V. L., Luke, B., Brown, M. B., Alvero, R., Frattarelli, J. L., & Armstrong, A. Y. (2010). Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. FERTILITY AND STERILITY, 94(4), 1410-1416.

Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe
Baker, V. L., Jones, C. E., Cometti, B., Hoehler, F., Salle, B., & Soules, M. R. (2010). Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe. FERTILITY AND STERILITY, 94(4), 1287-1291.

A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis
Davis, L. B., Champion, S. J., Fair, S. O., Baker, V. L., & Garber, A. M. (2010). A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. FERTILITY AND STERILITY, 93(6), 1793-1804.

The sex ratio of singleton offspring in assisted-conception pregnancies
Luke, B., Brown, M. B., Grainger, D. A., Baker, V. L., Ginsburg, E., & Stern, J. E. (2009). The sex ratio of singleton offspring in assisted-conception pregnancies. FERTILITY AND STERILITY, 92(5), 1579-1585.

Oocyte retrieval versus conversion to intrauterine insemination in patients with poor response to gonadotropin therapy
Shahine, L. K., Lathi, R. B., & Baker, V. L. (2009). Oocyte retrieval versus conversion to intrauterine insemination in patients with poor response to gonadotropin therapy. FERTILITY AND STERILITY, 92(4), 1315-1317.

Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis
Nicholas, C. R., Chavez, S. L., Baker, V. L., & Pera, R. Ar. (2009). Instructing an Embryonic Stem Cell-Derived Oocyte Fate: Lessons from Endogenous Oogenesis. ENDOCRINE REVIEWS, 30(3), 264-283.

Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial
Baker, V. L., Fujimoto, V. Y., Kettel, L. M., Adamson, G. D., Hoehler, F., & Soules, M. R. (2009). Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. FERTILITY AND STERILITY, 91(4), 1005-1011.

Balancing the professional and personal
Armstrong, A. Y., Alvero, R. J., Dunlow, S., Nace, M. C., Baker, V., & Stewart, E. A. (2009). Balancing the professional and personal. FERTILITY AND STERILITY, 91(1), 18-21.

Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing
Baker, V. L., Rone, H. M., & Adamson, G. D. (2008). Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing. FERTILITY AND STERILITY, 90(6), 2091-2098.

Economic cost for implementation of the US Food and Drug Administration's Code of Federal Regulations Title 21, Part 1271 in an egg donor program
Baker, V. L., Gvakharia, M. O., Rone, H. M., Manalad, J. R., & Adamson, D. (2008). Economic cost for implementation of the US Food and Drug Administration's Code of Federal Regulations Title 21, Part 1271 in an egg donor program. FERTILITY AND STERILITY, 90(3), 537-545.

Use of progesterone in three challenging cases.
Carson S, Baker VL, Liu J, & Wysocki S. (2008). Use of progesterone in three challenging cases. Sexuality, Reproduction, and Menopause.

A new SERM on the horizon.
Baker VL. (2008). A new SERM on the horizon. Female Patient, 33.

Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization
Baker, V. L., Rone, H. M., Pasta, D. J., Nelson, H. P., Gvakharia, M., & Adamson, G. D. (2006). Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 194(6), 1668-1674.

Multiple births from assisted reproductive technologies: a challenge that must be met
Adamson, D., & Baker, V. (2004). Multiple births from assisted reproductive technologies: a challenge that must be met. FERTILITY AND STERILITY, 81(3), 517-522.

Subfertility: causes, treatment and outcome
Adamson, G. D., & Baker, V. L. (2003). Subfertility: causes, treatment and outcome. BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 17(2), 169-185.

Selective estrogen receptor modulators in reproductive medicine and biology
Baker, V. L., Leitman, D., & Jaffe, R. B. (2000). Selective estrogen receptor modulators in reproductive medicine and biology. OBSTETRICAL & GYNECOLOGICAL SURVEY, 55(7), S21-S47.

Downregulation of protein kinase C by phorbol ester increases expression of epidermal growth factor receptors in transformed trophoblasts and amplifies human chorionic gonadotropin production
Baker, V. L., Murai, J. T., & Taylor, R. N. (1998). Downregulation of protein kinase C by phorbol ester increases expression of epidermal growth factor receptors in transformed trophoblasts and amplifies human chorionic gonadotropin production. PLACENTA, 19(7), 475-482.

Minimum intrauterine pressure required for uterine distention
Baker, V. L., & Adamson, G. D. (1998). Minimum intrauterine pressure required for uterine distention. JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 5(1), 51-53.

Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles
Baker, V. L., Draper, M., Paul, S., Allerheiligen, S., Glant, M., & Jaffe, R. B. (1998). Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 83(1), 6-13.

Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors
Baker, V. L., Chao, V. A., Murai, J. T., Zaloudek, C. J., & Taylor, R. N. (1997). Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 4(6), 316-324.

Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation
Baker, V. L., Givens, C. R., & Cadieux, M. Cm. (1997). Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 176(6), 1384-1385.

Clinical uses of antiestrogens.
Baker, V. L., & Jaffe, R. B. (1996). Clinical uses of antiestrogens. Obstetrical & gynecological survey, 51(1), 45-59.

THRESHOLD INTRAUTERINE PERFUSION PRESSURES FOR INTRAPERITONEAL SPILL DURING HYDROTUBATION AND CORRELATION WITH TUBAL ADHESIVE DISEASE
Baker, V. L., & Adamson, G. D. (1995). THRESHOLD INTRAUTERINE PERFUSION PRESSURES FOR INTRAPERITONEAL SPILL DURING HYDROTUBATION AND CORRELATION WITH TUBAL ADHESIVE DISEASE. FERTILITY AND STERILITY, 64(6), 1066-1069.

ALTERNATIVES TO ORAL ESTROGEN REPLACEMENT - TRANSDERMAL PATCHES, PERCUTANEOUS GELS, VAGINAL CREAMS AND RINGS, IMPLANTS, AND OTHER METHODS OF DELIVERY
Baker, V. L. (1994). ALTERNATIVES TO ORAL ESTROGEN REPLACEMENT - TRANSDERMAL PATCHES, PERCUTANEOUS GELS, VAGINAL CREAMS AND RINGS, IMPLANTS, AND OTHER METHODS OF DELIVERY. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 21(2), 271-297.

Surrogacy: one physician's view of the role of law.
Baker, V. L. (1994). Surrogacy: one physician's view of the role of law. University of San Francisco law review. University of San Francisco. School of Law, 28(3), 603-612.